Suppr超能文献

利什曼原虫脂磷壁酸对吞噬溶酶体生物合成的抑制作用。

Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan.

作者信息

Desjardins M, Descoteaux A

机构信息

Département d'anatomie,Université de Montréal, Montréal, Québec, Canada, H3C 3J7.

出版信息

J Exp Med. 1997 Jun 16;185(12):2061-8. doi: 10.1084/jem.185.12.2061.

Abstract

Whereas amastigotes of the protozoan parasite Leishmania proliferate inside acidic phagolysosomal vacuoles of the macrophage, vacuoles induced by Leishmania donovani promastigotes during initiation of infection are poorly characterized. Here, evidence is presented that interaction of these parasitophorous vacuoles with endocytic organelles is very limited. In contrast, vacuoles formed around L. donovani mutants lacking the cell surface lipophosphoglycan (LPG) fuse extensively with endosomes and lysosomes. The role of LPG repeating units in the inhibition of phagosome-endosome fusion was demonstrated using two different approaches. First, genetic complementation of the LPG-defective C3PO mutant restored its ability to inhibit phagosome-endosome fusion to a degree similar to that of wild-type promastigotes. Second, opsonization of C3PO mutant cells with purified L. donovani LPG also conferred to this mutant the ability to inhibit phagosome-endosome fusion. Inasmuch as LPG is essential for infecting macrophages, these results suggest that inhibition of phagolysosomal biogenesis by LPG repeating units represents an intramacrophage survival strategy used by promastigotes to establish infection.

摘要

原生动物寄生虫利什曼原虫的无鞭毛体在巨噬细胞的酸性吞噬溶酶体空泡内增殖,而杜氏利什曼原虫前鞭毛体在感染起始阶段诱导形成的空泡特征尚不明确。本文提供的证据表明,这些寄生泡与内吞细胞器的相互作用非常有限。相比之下,缺乏细胞表面脂磷壁酸(LPG)的杜氏利什曼原虫突变体周围形成的空泡与内体和溶酶体广泛融合。使用两种不同方法证明了LPG重复单元在抑制吞噬体-内体融合中的作用。首先,LPG缺陷型C3PO突变体的基因互补恢复了其抑制吞噬体-内体融合的能力,其程度与野生型前鞭毛体相似。其次,用纯化的杜氏利什曼原虫LPG对C3PO突变体细胞进行调理也赋予该突变体抑制吞噬体-内体融合的能力。鉴于LPG对感染巨噬细胞至关重要,这些结果表明,LPG重复单元对吞噬溶酶体生物合成的抑制代表了前鞭毛体用于建立感染的一种巨噬细胞内存活策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/2196352/eab0aa562ad8/JEM.962224f2.jpg

相似文献

1
Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan.
J Exp Med. 1997 Jun 16;185(12):2061-8. doi: 10.1084/jem.185.12.2061.
5
Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane.
Cell Microbiol. 2006 Dec;8(12):1922-31. doi: 10.1111/j.1462-5822.2006.00758.x. Epub 2006 Jul 11.
6
Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania.
Clin Immunol. 2005 Mar;114(3):256-65. doi: 10.1016/j.clim.2004.07.018.
7
Contribution of electron and confocal microscopy in the study of Leishmania-macrophage interactions.
Microsc Microanal. 2004 Oct;10(5):656-61. doi: 10.1017/S1431927604040851.
8
Leishmania donovani requires functional Cdc42 and Rac1 to prevent phagosomal maturation.
Infect Immun. 2006 May;74(5):2613-8. doi: 10.1128/IAI.74.5.2613-2618.2006.
10
Exclusion of synaptotagmin V at the phagocytic cup by Leishmania donovani lipophosphoglycan results in decreased promastigote internalization.
Microbiology (Reading). 2011 Sep;157(Pt 9):2619-2628. doi: 10.1099/mic.0.050252-0. Epub 2011 Jun 16.

引用本文的文献

1
Are basic and lipophilic chain groups highly required in leishmanicidal quinolines to favor the phagolysosome accumulation?
Front Chem. 2025 Aug 21;13:1655979. doi: 10.3389/fchem.2025.1655979. eCollection 2025.
2
Impact of 2D versus 3D fibroblast models on species invasion : Rab5 dynamics and actin activity in initial infection.
Front Cell Infect Microbiol. 2025 Aug 18;15:1654654. doi: 10.3389/fcimb.2025.1654654. eCollection 2025.
3
VAPA mediates lipid exchange between Leishmania amazonensis and host macrophages.
PLoS Pathog. 2025 Mar 31;21(3):e1012636. doi: 10.1371/journal.ppat.1012636. eCollection 2025 Mar.
5
Advances in Vaccines: Current Development and Future Prospects.
Pathogens. 2024 Sep 20;13(9):812. doi: 10.3390/pathogens13090812.
6
Neutrophils versus Protozoan Parasites: , , , , and .
Microorganisms. 2024 Apr 19;12(4):827. doi: 10.3390/microorganisms12040827.
7
Genetic variation of FcγRIIa induces higher uptake of and modulates cytokine production by adherent mononuclear cells .
Front Immunol. 2024 Feb 22;15:1343602. doi: 10.3389/fimmu.2024.1343602. eCollection 2024.
9
Induced pluripotent stem cell-derived human macrophages as an infection model for Leishmania donovani.
PLoS Negl Trop Dis. 2024 Jan 2;18(1):e0011559. doi: 10.1371/journal.pntd.0011559. eCollection 2024 Jan.
10
Immunopathological Mechanisms Underlying Cardiac Damage in Chagas Disease.
Pathogens. 2023 Feb 16;12(2):335. doi: 10.3390/pathogens12020335.

本文引用的文献

1
The lipophosphoglycan of Leishmania and macrophage protein kinase C.
Parasitol Today. 1993 Dec;9(12):468-71. doi: 10.1016/0169-4758(93)90105-o.
2
Biogenesis of phagolysosomes: the 'kiss and run' hypothesis.
Trends Cell Biol. 1995 May;5(5):183-6. doi: 10.1016/s0962-8924(00)88989-8.
4
Protein phosphorylation during phagosome maturation.
FEBS Lett. 1996 Nov 25;398(1):37-42. doi: 10.1016/s0014-5793(96)01213-6.
6
Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani.
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11634-9. doi: 10.1073/pnas.93.21.11634.
8
Identification of genes mediating lipophosphoglycan biosynthesis by functional complementation of Leishmania donovani mutants.
Ann Trop Med Parasitol. 1995 Dec;89 Suppl 1:11-17. doi: 10.1080/00034983.1995.11813009.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验